Breathe Well Live Well
Newsday |
Study looks at stepping down asthma medicines
Newsday Stepping down asthma medicines can be done safely and at a lower cost for patients, says a new Mayo Clinic study published recently in The Journal of Allergy and Clinical Immunology. It is common for patients and doctors to test if taking less daily … Home-based educational intervention improves asthma among Hispanic children American College of Allergy, Asthma & Immunology, Nov. 5-9 |
View full post on asthma – Google News
|
Stepping down on asthma medicines is viable option
azcentral.com Answer: Sometimes patients and their healthcare team may want to test out if taking less daily asthma medicine is safe. Trying to reduce daily asthma medicine use in asthma patients speaks to the principle of using the least amount of medicine to … |
View full post on asthma – Google News
WCPO |
Asthma medicines can cause problems for youngest users, new research say
WCPO CINCINNATI – Common asthma medicines can stunt your child's growth earlier than had been found, according to new research. The most chronic of childhood diseases affects 5 million children in the United States. And now, research indicates problems with … |
View full post on asthma – Google News
|
Teva Announces European Medicines Agency (EMA) Confirms Successful Validation …
MarketWatch “Uncontrolled asthma remains a serious challenge for patients and healthcare professionals despite the availability of standard of care treatment,” said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical … |
View full post on asthma – Google News
Monthly Prescribing Reference |
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in … GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD New Inhalers for Asthma, COPD Launched GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
Monthly Prescribing Reference |
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US … New Inhalers for Asthma, COPD Launched GSK Expands Portfolio of Asthma/COPD Medicines in U.S. GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
|
Asthma's treatment pipeline very strong as more personalized medicines emerge
The Pharma Letter According to research and consulting firm GlobalData's latest report, the most significant challenge in asthma therapeutics is posed by patients with severe forms of the disease, who remain uncontrolled and have frequent exacerbations, even with the … |
View full post on asthma – Google News
spyghana.com |
Asthma medicines Introduced
spyghana.com Dr Audrey Forson, Professor Bamenla Goka of Korle-bu Teaching Hospital, both leading Asthma Care physicians for adults and children and Dr Phillip Ikeme, Medical Affairs Manager MSD Sub-Saharan Africa spoke on the management of asthma, … |
View full post on asthma – Google News
India.Com Health |
Medicines for asthma — use, side-effects, overdose and interactions
India.Com Health asthma medicines Asthma is a chronic condition in which a person suffers from breathing difficulties due to inflammation of the air passage. It can develop at any age but is more commonly found in children. These days, more number of people are … |
View full post on asthma – Google News
|
Are your kids' asthma medicines too pricey?
Atlanta Journal Constitution (blog) It's allergy and asthma season across the United States and for families even with insurance the cost of asthma medicines can be prohibitive. Asthma is often easily prevented and controlled with the right inhalable medicines but due to patents, FDA … Asthma medicines a struggle for many countries |
View full post on asthma – Google News